POM-V Prescription Required

Animeloxan 20 mg/ml Solution for Injection for Cattle, Pigs and Horses

Active ingredient: Meloxicam

Form

Injection

Species

Cattle Horses Pigs

Manufacturer

aniMedica GmbH

VMD MA No.

24745/4015

What it's used for

For use in diarrhoea in combination with oral re-hydration therapy to reduce clinical signs in calves of over one week of age and young, non-lactating catt...

Full indications, dosage and side effects ↓

View official SPC (PDF)

The prescription itself has a price. See what practices near you charge for a consultation and the written prescription fee.

Paying less for Meloxicam

1

Ask your vet for a written prescription

They must provide one on request. Under the CMA Order the fee is capped at £21 from 2027.
2

Fill it at a registered online retailer

The CMA found online pharmacies 50–60% cheaper than practice dispensing on common medicines — typically £200–£300 a year.

Your prescription rights → VMD register of retailers →

Prescription required

Your vet must provide a written prescription on request. You can then purchase from any licensed online retailer.

Clinical information

Animeloxan 20 mg/ml Solution for Injection for Cattle, Pigs and Horses — SPC Details

Source: VMD Summary of Product Characteristics (SPC). Last updated 27 Mar 2026.

For use in diarrhoea in combination with oral re-hydration therapy to reduce clinical
signs in calves of over one week of age and young, non-lactating cattle.
For adjunctive therapy in the treatment of acute mastitis, in combination with
antibiotic therapy.
For the relief of post-operative pain following dehorning in calves.
AN: 00937/2024 & 00938/2024
Pigs:
For use in non-infectious locomotor disorders to reduce the symptoms of lameness
and inflammation.
For adjunctive therapy in the treatment of puerperal septicaemia and toxaemia
(mastitis-metritis-agalactia syndrome) with appropriate antibiotic therapy.
Horses:
For use in the alleviation of inflammation and relief of pain in both acute and chronic
musculo-skeletal disorders.
For the relief of pain associated with equine colic.

Cattle:
Single subcutaneous or intravenous use at a dosage of 0.5 mg meloxicam/kg body
weight (i.e. 2.5 ml/100 kg body weight) in combination with antibiotic therapy or with
oral re-hydration therapy, as appropriate.
Pigs:
Single intramuscular use at a dosage of 0.4 mg meloxicam/kg body weight (i.e. 2.0
ml/100 kg body weight) in combination with antibiotic therapy, as appropriate. If
required, a second administration of meloxicam can be given after 24 hours.
Alternating injection sites are recommended.
Horses:
Single intravenous use at a dosage of 0.6 mg meloxicam/kg body weight (i.e. 3.0
ml/100 kg body weight).
AN: 00937/2024 & 00938/2024

See also section 3.7.
Do not use in horses less than 6 weeks of age.
Do not use in cases of impaired hepatic, cardiac or renal function and haemorrhagic
disorders, or where there is evidence of ulcerogenic gastrointestinal lesions.
Do not use in cases of hypersensitivity to the active substance or to any of the
excipients.
For the treatment of diarrhoea in cattle, do not use in animals of less than one week
of age.

Cattle:
Rare
(1 to 10 animals / 10,000
animals treated):
Anaphylactoid reaction
Undetermined frequency
(cannot be estimated from the
available data):
Injection site swelling
Pigs:
Rare
(1 to 10 animals / 10,000
animals treated):
Anaphylactoid reaction
Undetermined frequency
(cannot be estimated from the
available data):
Injection site irritation
Horses:
Rare
(1 to 10 animals / 10,000
animals treated):
Anaphylactoid reaction
Undetermined frequency
(cannot be estimated from the
available data):
Injection site swelling
1
May be serious (including fatal); should be treated symptomatically.
After single subcutaneous injection; non-painful; can last up to 23 days.
After two consecutive intramuscular injections; can last up to 9 days.
Transient; resolves without intervention.
AN: 00937/2024 & 00938/2024
If adverse events occur, treatment should be discontinued and the advice of a
veterinarian should be sought.
Reporting adverse events is important. It allows continuous safety monitoring of a
veterinary medicinal product. Reports should be sent, preferably via a veterinarian, to
either the marketing authorisation holder or its local representative or the national
competent authority via the national reporting system. See the package leaflet for
respective contact details.

Treatment of calves with the veterinary medicinal product 20 minutes before
dehorning reduces post-operative pain. The veterinary medicinal product alone will
not provide adequate pain relief during the dehorning procedure. To obtain adequate
pain relief during surgery, co-medication with an appropriate analgesic is needed.

Special precautions for safe use in the target species:
Avoid use in very severely dehydrated, hypovolaemic or hypotensive animals which
require parenteral rehydration, as there may be a potential risk of renal toxicity.
In case of inadequate relief of pain when used in the treatment of equine colic,
careful re-evaluation of the diagnosis should be made as this could indicate the need
for surgical intervention.
Special precautions to be taken by the person administering the veterinary medicinal
product to animals:
Accidental self-injection may give rise to pain. People with known hypersensitivity to
non-steroidal anti-inflammatory drugs (NSAIDs) should avoid contact with the
veterinary medicinal product.
In case of accidental self-injection, seek medical advice immediately and show the
package leaflet or the label to the physician.
If accidental skin contact occurs, wash the affected area thoroughly.
Wash hands after use.
AN: 00937/2024 & 00938/2024
NSAIDs and other prostaglandin inhibitors are known to have adverse effects on
pregnancy and/or embryofoetal development.
Laboratory studies in rabbits and rats with the excipient N-methyl pyrrolidone have
shown evidence of foetotoxic effects.
Women of childbearing age, pregnant women or women suspected of being pregnant
should use the veterinary medicinal product with serious caution to avoid accidental
self-injection.
Special precautions for the protection of the environment:
Not applicable.

Do not administer concurrently with glucocorticosteroids, other non-steroidal anti-
inflammatory drugs or with anti-coagulant agents.

This veterinary medicinal product does not require any special temperature storage
conditions.

Cattle:
Meat and offal: 15 days
Milk: 5 days
Pigs:
Meat and offal: 8 days
Horses:
Meat and offal: 5 days
Do not use in horses producing milk for human consumption.

This information is sourced from the official Summary of Product Characteristics (SPC) published by the Veterinary Medicines Directorate (VMD). It is provided for informational purposes only and does not replace professional veterinary advice. Always consult your vet before administering any medication.